Finding Leukemia’s Weakness Using Genome-Wide CRISPR Technology
Researchers at University of California San Diego School of Medicine and Moores Cancer Center used CRISPR technology to identify key regulators of aggressive chronic myeloid leukemia.
Alumni
The Latest
UC San Diego Researchers Optimize Microbiome Tool for Computer GPUs
UC San Diego researchers have ported the popular UniFrac microbiome tool to graphic processing units (GPUs) to increase the acceleration and accuracy of scientific discovery including urgently needed COVID-19 research.
UC San Diego Health Launches Novel Coronavirus Blood Testing to Identify Past Exposure
Physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies—evidence in persons tested that they have previously been infected by the viral cause of COVID-19, even if they never experienced tell-tale symptoms.
Economic Impact of COVID-19 will Make the Fight Against Climate Change Harder
Measures to slow the spread of the coronavirus have reduced the demand for fuel and slashed oil prices. Global emissions of carbon dioxide (CO2), the chief long-term cause of climate warming, have slid perhaps by one-fifth, but can we expect COVID-19 to create lasting change for the planet?
SDSC Researchers Develop Potential COVID-19 Protease Inhibitors
UC San Diego researchers recently created a pharmacophore model and conducted data mining of the conformational database of FDA-approved drugs that identifies 64 compounds as potential inhibitors of the COVID-19 protease.
When Damaged, the Adult Brain Repairs Itself by Going Back to the Beginning
When adult brain cells are injured, they revert to an embryonic state, say researchers at UC San Diego School of Medicine. In their newly adopted immature state, the cells become capable of re-growing new connections that, under the right conditions, can help to restore lost function.
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
